Ranjan Grover is the chief investment officer and portfolio manager for Leavenworth Capital.

Leavenworth CapitalRead More

You might also be interested in reading PulseSight Therapeutics announces the initiation of the clinical plan of PST-611, Transferrin Vectorized Therapy for dry AMD/Geographic Atrophy.